Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10767342 | Biochemical and Biophysical Research Communications | 2007 | 6 Pages |
Abstract
Rats fed a high-fat diet showed a greater increase in body weight than those fed a standard diet (P < 0.05), and treatment with L-165041 (10 mg/kg/day) significantly decreased weight gain (P < 0.05). The concentration of total cholesterol was lower, and HDL cholesterol was higher in L-165041-treated rats (P < 0.05). In the visceral adipose tissue of L-165041-treated rats, visfatin and adiponectin mRNA levels significantly increased compared to those of the untreated rats (P < 0.05). However, the expression of resistin decreased in the L-165041-treated rats. Furthermore, in cultured 3T3-L1 adipocytes, the level of visfatin and adiponectin mRNA was up-regulated in response to L-165041 treatment for nine days. By contrast, resistin mRNA levels were down-regulated by L-165041 treatment. The present study provides a novel evidence to suggest that the PPAR-δ agonist has regulatory effects on a variety of adipokines, and these effects might explain some of their metabolic function.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
K.C. Choi, S.Y. Lee, H.J. Yoo, O.H. Ryu, K.W. Lee, S.M. Kim, S.H. Baik, K.M. Choi,